{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-002037","form_type":"8-K","ticker":"CRDF","cik":"0001213037","company_name":"Cardiff Oncology, Inc.","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.092506+00:00","generated_at":"2026-06-20T01:54:53.089391+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cardiff Oncology appoints Fairooz Kabbinavar as Chief Medical Officer","bullets":["Annual base salary $480,000, target bonus 45% of base, plus option grant.","Granted non-qualified option for 425,000 shares at $1.75/share exercise price.","Options vest over 4 years: 25% after 12 months, then monthly over 36 months.","Dr. Kabbinavar has 30+ years experience; lead investigator for bevacizumab mCRC approval trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-002037","json":"https://secwatch.observer/filing/0001628280-23-002037.json","markdown":"https://secwatch.observer/filing/0001628280-23-002037.md","text":"https://secwatch.observer/filing/0001628280-23-002037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023002037/0001628280-23-002037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023002037/crdf-20230202.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T01:54:53.089391+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cea165c126","claim":"Fairooz Kabbinavar was appointed as Chief Medical Officer at Cardiff Oncology, Inc..","evidence_excerpt":"On January 30, 2023, Cardiff Oncology, Inc. (the “Company”) appointed Dr. Fairooz Kabbinavar as Chief Medical Officer of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1213037/000162828023002037/0001628280-23-002037-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}